Skip to main content

Table 1 Preoperative patients details

From: St. Jude Medical Trifecta aortic valve: results from a prospective regional multicentre registry

Variablesa All implants (n = 178)
Demographics  
 Age, yrs 75.4 ± 7.7 (72-81)
 Female, n (%) 83 (46.6)
 BSA, m2 1.60 ± 0.33 (1.38-1.79)
Cardiac presentation  
 Previous AMI, n (%) 22 (12.4)
 CAD, n (%) 68 (38.2)
 History of AF, n (%) 25 (14.0)
 Preoperative NYHA, n (%)  
  Class I 13 (7.3)
  Class II 72 (40.4)
  Class III 78 (43.8)
  Class IV 15 (8.4)
Comorbidities  
 Hypertension, n (%) 136 (76.4)
 Diabetes, n (%) 49 (27.5)
 COPD, n (%) 24 (13.5)
 PVD, n (%) 52 (29.2)
 Dyslipidemia, n (%) 83 (46.6)
 Renal dysfunction, n (%) 13 (7.3)
 Renal failure-dialysis, n (%) 7 (3.9)
 Logistic EuroSCORE, % 7.7 ± 6.7 (3.0-11.0)
Etiology  
 Calcified, n (%) 120 (67.4)
 Rheumatic, n (%) 11 (6.2)
 Degenerative, n (%) 35 (19.7)
 Annular dilatation, n (%) 5 (2.8)
 Endocarditis, n (%) 7 (3.9)
  1. aFor continuous variables, mean ± SD (interquartile range); categorical data, count (percentage)
  2. AF atrial fibrillation, AMI acute myocardial infarction, BSA body surface area, CAD coronary artery disease, COPD chronic obstructive pulmonary disease, NYHA New York Heart Association, PVD peripheral vascular disease